Synagis (palivizumab) 50 mg/0.5 mL, 1 vial, AbbVie Synagis (palivizumab) is used to help prevent serious respiratory syncytial virus (RSV) lower respiratory tract disease in high-risk children. Contact +380996042415.
Delivery methods
- Delivery of non-temperature-controlled medicines to Chisinau - $25.
Delivery of temperature-controlled medicines to Chisinau - $50.
Up to 5 packages can be sent per shipment. The price applies to one shipment. - Pickup from Odesafree
- Shipping within Ukraine by Nova Poshta at the carrier's rates.
Payment in UAH upon receipt of the order.
Delivery time
- Originator medicines: 5-7 days
- Generic medicines: 3-4 days
Payment methods
- Bank transfer to the settlement account after receiving the order
- Payment upon pickup in Odesa
Indications of the active substances of the drug Synagis®
Prevention of severe lower respiratory tract infection caused by respiratory syncytial virus (RSV) in children at high risk of RSV infection, which include: children under 6 months of age born at 35 weeks of gestation or earlier; children under 2 years of age who have required treatment for bronchopulmonary dysplasia within the past 6 months; children under 2 years of age with hemodynamically significant congenital heart defects.
- Trade name:Synagis
- Chemical name:Palivizumab
- Dosage:50 mg
- Quantity:1
- Dosage form:Vial
No reviews yet
